Awakn Life Sciences
A biotechnology company with clinical operations, developing and delivering psychedelic therapeutics to better treat addiction. Learn more
Launch date
Employees
Market cap
€3.0m
Enterprise valuation
€3m (Public information from Feb 2024)
Share price
CAD0.19 AWKN.NE
Company register number 12767250
London England (HQ)
Authorizing premium user...